Table 1 Profile of patients whereas on conventional haemodialysis immediately before shifting to short daily haemodialysis
Variables | All patients | FO ≤15% | FO > 15% | P value |
|---|---|---|---|---|
(n = 297) | (n = 118) | (n = 102) | ||
FO (%ECV)§ | 13.8 (5.1–22.1) | 6.2 (1.9–10.4) | 23.9 (17.8–30.0) | – |
Age (years) | 57 (45–67) | 53 (39–63) | 61 (48–70) | < 0.0001 |
Male gender, n (%) | 189 (63.6) | 70 (59.3) | 70 (68.6) | 0.16 |
Diabetes, n (%) | 128 (43.1) | 43 (36.4) | 52 (51.0) | 0.04 |
Charlson comorbidity index | 4 (2-4) | 3 (2-4) | 4 (2–4) | 0.018 |
Vintage (months) | 29 (13-61) | 33 (13-61) | 29 (16-70) | 0.38 |
HBsAg+, n (%) | 3 (1.0) | 1 (0.8) | 1 (1.0) | 1.00 |
Anti-HCV+, n (%) | 9 (3.0) | 4 (3.4) | 3 (3.0) | 1.00 |
Anti-HIV+, n (%) | 6 (2.0) | 4 (3.4) | 1 (1.0) | 0.39 |
Vascular access, n (%) | ||||
Native AFV | 210 (70.7) | 97 (82.2) | 69 (67.6) | 0.018 |
Graft | 13 (4.4) | 6 (5.1) | 2 (2.0) | 0.29 |
Catheter | 74 (24.9) | 15 (12.7) | 31 (30.4) | 0.002 |
Treatment time (min/session) | 240 ± 10 | 239 ± 10 | 240 ± 10 | 0.36 |
Equilibrated KT/V | 1.28 ± 0.35 | 1.29 ± 0.37 | 1.27 ± 0.33 | 0.81 |
Body mass index (Kg/m2) | 25.5 ± 5.6 | 26.8 ± 6.2 | 24.0 ± 5.0 | < 0.0001 |
Body weight (Kg) | 71.0 ± 17.3 | 74.8 ± 18.8 | 67.3 ± 15.1 | 0.0003 |
UF rate (mL/hour/Kg) | 9.9 ± 3.5 | 9.9 ± 3.4 | 10.1 ± 3.6 | 0.71 |
Predialysis SBP (mmHg) | 139 ± 21 | 138 ± 19 | 141 ± 22 | 0.19 |
Predialysis DBP (mmHg) | 76 ± 13 | 77 ± 12 | 74 ± 14 | 0.018 |
Postdialysis SBP (mmHg) | 134 ± 20 | 132 ± 18 | 138 ± 22 | 0.008 |
Postdialysis DBP (mmHg) | 75 ± 12 | 76 ± 12 | 74 ± 13 | 0.12 |
Haemoglobin (g/dL) | 10.5 ± 1.9 | 10.9 ± 1.8 | 10.1 ± 1.9 | 0.002 |
Serum albumin (g/L) | 37.7 ± 4.8 | 39.1 ± 4.0 | 37.0 ± 5.2 | 0.0002 |
Phosphorus (mg/dL) | 5.1 ± 1.6 | 5.3 ± 1.5 | 5.1 ± 1.7 | 0.24 |